New York – Oct 10, 2016 – A report added by Axiom Market Research & Consulting on Asia Pacific clinical chemistry analyzers. The report estimated the clinical chemistry market in Asia-Pacific is projected to grow at a CAGR of 10.6% from 2015 to 2021. The market is studied for clinical chemistry analyzer types such as reagents and devices further dividing reagents into metabolites, enzymes, electrolytes, and others; and devices into semi-automatic devices and fully automatic devices consisting of entry level, medium throughput, high throughput and high throughput modular analyzers.
The major tests considered in the study are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel and specialty chemicals. The market for end users is analyzed for hospitals, diagnostic laboratories, academic institutes, and others such as blood banks, cancer research centers, military hospitals etc. The Asia-Pacific clinical chemistry market is analyzed for Japan, China, India, and others consisting of Vietnam, Singapore, Malaysia, Australia, Thailand, New Zealand among others.
BROWSE THE REPORT DETAILS: https://goo.gl/nYhXoc
Major drivers and restraints of the market
The market is driven by growing healthcare reforms and infrastructure in developing countries, and increasing awareness for preventive healthcare. Rising occurrence of chronic diseases along with growing aging population demands more clinical chemistry analyser devices to conduct multiple tests for accurate diagnosis in countries like China and Japan. There is high participation of government in healthcare sector in many Asian countries paving way for rising demand for clinical chemistry analyzers for disease diagnosis. The market growth is restrained mainly due to tough government regulations along with restricted expenditure on healthcare due to preference for traditional ways of medical care.
Reagents and consumables segment accounts for the largest market share
Among the types of clinical chemistry analyzers, the market for reagents and consumables is higher than devices. Among the reagents, metabolites are the used on a larger scale followed by enzyme and electrolytes.
Hospitals dominated the market for clinical chemistry by end users
The end users considered in the clinical chemistry market are hospitals, diagnostic laboratories, academic institutions, and others such as blood banks, cancer research centers. The hospitals segment dominated the market in 2015 followed by diagnostic laboratories and academic institutions. The demand for clinical chemistry analyzers is increasing rapidly in the hospitals due changing infrastructure for making hospitals well-equipped with new diagnostic devices and rising number of hospitals in the developing countries.
DOWNLOAD THE REPORT BROCHURE: https://goo.gl/z60tIq
Rising awareness about different diagnostic tests, increasing government participation in the healthcare sector and high investment by the leading players is leading to the growth of clinical chemistry analyzers market in Asia-Pacific region.
China dominated the market with the largest market share followed by Japan and India. Rest of Asian countries also contribute to a great extent to the clinical chemistry analyzers market. The leading players in this industry Abbott Laboratories, Becker Coulter (Acquired by Danaher Corporation), Johnson & Johnson, Ortho-Clinical Diagnostics, Inc., F. Hoffmann-La Roche, Siemens AG, Thermo Fisher Scientific Inc., Horiba Ltd, Elitech Group, Randox Laboratories Ltd, Mindray Medical International Limited., among others. These companies have established their position in the market by offering competent products.
Other Reports from Axiom MR on Clinical Chemistry Analyzers Market:
Company Name: Axiom MRC
Contact Person: John Stadler
Phone: +1 (845) 875-9786
Address:616 Corporate Way, Suite 2-4268
City: Valley Cottage
Country: United States